Cornell Tech, the groundbreaking campus of Cornell University dedicated to developing leaders and technologies for the AI era, has announced the opening of The Bridge, a new state-of-the-art flexible workspace for entrepreneurs, early and mid-stage ventures, and more established companies.
Weill Cornell Medicine has received a projected $4 million grant to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.
The Cornell Atkinson Center for Sustainability and long-time collaborator Environmental Defense Fund announce their 2025 awardees for joint research and seek new proposals for 2026 initiatives.
A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine.
Researchers at Weill Cornell Medicine have discovered that a parasite that causes malaria when transmitted through a mosquito bite can shut down a key set of genes, rendering itself “immunologically invisible” — sometimes for years.
The health care industry is increasingly relying on AI – in responding to patient queries, for example – and a new Cornell study shows how decision-makers can use real-world data to build sustainability into new systems.
The 2024 XR Access Symposium, held at Cornell Tech in New York City, brought together industry leaders, researchers, and advocates to discuss the role of extended reality (XR) in fostering digital accessibility.
Under the theme …
A new study by researchers at Cornell Tech and the University of Pennsylvania shows freelance writers who are suspected of using AI have worse evaluations and hiring outcomes.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.